Home » Authors » Brady Huggett

Articles by Brady Huggett

Europeans Continue Struggling To Blend The Colors Of Biotech

Dec. 3, 2003

By Brady Huggett

Europeans Continue Struggling To Blend The Colors Of Biotech

Dec. 3, 2003

By Brady Huggett

Protein Forest's Series A Raises $19M For ProteomeChip Launch

Nov. 24, 2003

By Brady Huggett

Protein Forest's Series A Raises $19M For ProteomeChip Launch

Nov. 24, 2003

By Brady Huggett

With Phase III Ongoing, Repligen Presents Preclinical Secretin Data

Nov. 13, 2003

By Brady Huggett

With Phase III Ongoing, Repligen Presents Preclinical Secretin Data

Nov. 13, 2003

By Brady Huggett

Corixa Reports Third-Quarter Results, Restructuring Plans

Nov. 10, 2003

By Brady Huggett

Corixa Reports Third-Quarter Results, Restructuring Plans

Nov. 10, 2003

By Brady Huggett

Pursuing Growth Via Acquisition Strategy, Invitrogen Buys Sequitur

Nov. 6, 2003

By Brady Huggett

Pursuing Growth Via Acquisition Strategy, Invitrogen Buys Sequitur

Nov. 6, 2003

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...